Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 11 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 13 analysts offering 12 month price targets for BridgeBio Pharma Inc have a median target of 46.00, with a high estimate of 70.00 and a low estimate of 37.00. The median estimate represents a 77.20% increase from the last price of 25.96.
High | 169.6% | 70.00 |
Med | 77.2% | 46.00 |
Low | 42.5% | 37.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | -3.73% |
Average growth rate | -15.15% |
More ▼
Revenue history & estimates in USD
Average growth rate | +2,997.89% |
Average growth rate | +147.21% |
More ▼